from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3761c/fadE36

LFCtreatmentdescriptionclass of inhibitor

0.386

Amikacinug/mL Amikacintranslation

0.843

Cap5-10ug/mL Capreomycintranslation

0.263

Rox10-50 ug/mL Roxithromycintranslation

-0.160

SM2-5 ug/mL Streptomycintranslation

1.434

Tet5-10 ug/mL Tetracyclinetranslation

0.691

Rif0.2-5ug/mL Rifampicintranscription

-0.390

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.261

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.630

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.052

Clofazimine10-13 ug/mL Clofaziminerespiration

0.293

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.133

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.798

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.160

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.278

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.279

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.485

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.170

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.059

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.214

KCN5-20 ug/mL Potassium cyaniderespiration

0.459

NaN30.2-2 mM Sodium aziderespiration

0.643

Nigericin50 uM Nigericinrespiration

-0.051

TRC10-150 ug/mL Triclosanrespiration

0.752

TRZ10-25 ug/mL Thioridazinerespiration

0.194

Valinomycin0.5-10 uM Valinomycinrespiration

0.270

ZnSO42 mM ZnSO4respiration

0.449

menadione6-10 ug/mL Menadionerespiration

0.290

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.030

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.368

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.372

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.083

NRP_1Non-replicating persistence stage 1dosRassociated

-0.633

Amp0.2mg/mL AmpicillincellWall

0.537

Cephalexin20-100 ug/mL CephalexincellWall

0.662

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.257

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.347

EMB10-20 ug/mL EthambutolcellWall

-0.291

Eta12-40 ug/mL EthionamidecellWall

-0.255

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.008

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.004

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.093

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.401

BZA0.12 mg/mL BenzamidearomaticAmides

-0.290

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.327

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.062

H2O24 mM hydrogen peroxideDNAdamaging

0.297

Levo10 ug/mL LevofloxacinDNAdamaging

-0.910

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.210

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.090

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.894

UVUV-irradiationDNAdamaging

1.876

ARP41-4 ug/mL Antitubercular compound ARP4?

0.781

Antimycin12.5-50 ug/mL Antimycin A?

1.252

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.824

PA_110-50 ug/mL Antitubercular compound PA-1?

0.537

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.913

PA8240.2-2 ug/mL PA-824?

0.047

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.971

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.689

Verapamil50 uM Verapamil?

0.530

mercaptoethanol2 mM 2-Mercaptoethanol?

1.479

methoxatin10-20 ug/mL Methoxatin?